fda bpc-157 not approved warning peptide Five reasons adding peptides to the 503A bulk compounding lists may be more problematic than you realize – Partnership for Safe Medicines fda warning bpc-157 not approved
Description
13 describes an old soldier who was being treated for Systemic Lupus Erythematosus in Brisbane Veteran's Hospital, Australia, but was not being helped by traditional treatments

Cons: Requires precision, may cause slight discomfort
If fatigue persists beyond 6 weeks, message your provider through the dashboard for a protocol review
doi: 10.1053/j.ajkd.2019.12.020 [PubMed] 33096028 Li J, Ma H, Lei Y, Wan Q